Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee hears proponents on HB 33 to require coverage of PSA screening for high‑risk men
Summary
Supporters told the House Insurance Committee that House Bill 33 would require insurers to cover evidence‑based prostate cancer screening, such as PSA testing, without cost sharing for men at elevated risk after a clinician discussion.
The House Insurance Committee held a proponent hearing on House Bill 33, which would require health insurers to cover evidence‑based prostate cancer screening (including PSA testing) without out‑of‑pocket costs for men at elevated risk after a provider discussion.
Angela Dawson, director of the Ohio Commission on Minority Health, told the committee HB 33 would remove financial barriers that prevent men from accessing screening and catching prostate cancer early. “This legislation will remove the financial barriers that too often prevent men from accessing care and catching the disease early,” Dawson said in proponent testimony.
Dr. John DeLancey, a urologist at The Ohio State University Wexner Medical Center speaking for the American Urological Association, urged advancement of the bill and…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
